EcoDrugPlus

Solute Carrier Family 6 (Neurotransmitter Transporter, Dopamine), Member 3

Ensembl ID : ENSMSIG00000017069
Gene Symbol: SLC6A3
1 Cross references
181 Possible Orthologues:

Solute Carrier Family 6 (Neurotransmitter Transporter, Glycine), Member 9

Ensembl ID : ENSMSIG00000014862
Gene Symbol: SLC6A9
1 Cross references
222 Possible Orthologues:

Solute Carrier Family 6 (Neurotransmitter Transporter, Noradrenalin), Member 2

Ensembl ID : ENSMSIG00000021915
Gene Symbol: SLC6A2
1 Cross references
217 Possible Orthologues:

Solute Carrier Family 6 (Neurotransmitter Transporter, Serotonin), Member 4

Ensembl ID : ENSMSIG00000025438
Gene Symbol: SLC6A4
1 Cross references
218 Possible Orthologues:

Solute Carrier Family 9 (Sodium/hydrogen Exchanger), Member 3

Ensembl ID : ENSMSIG00000015760
Gene Symbol: SLC9A3
1 Cross references
249 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSMSIG00000004290
Gene Symbol: SSTR1
1 Cross references
173 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSMSIG00000010959
Gene Symbol: SSTR2
1 Cross references
278 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSMSIG00000021464
Gene Symbol: SSTR3
1 Cross references
264 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSMSIG00000002973
Gene Symbol: SSTR4
1 Cross references
115 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSMSIG00000012666
Gene Symbol: SSTR5
1 Cross references
271 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSMSIG00000018323
Gene Symbol: SPHK2
1 Cross references
224 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSMSIG00000005050
Gene Symbol: S1PR1
1 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).